ROTEM®- The standard of Patient care

It has been shown that besides better patient care, effective cost savings are possible by following a ROTEM® guided therapy.

Proven cost saving potential

The use of ROTEM® as a diagnostic tool in perioperative bleeding management is implemented in numerous guidelines like:

  • Trauma
  • Cardiac
  • Liver transplant

The cost saving potential of ROTEM®-guided therapy has repeatedly been proven. It has been shown to reduce unnecessary blood product use and clinical complications. The reduced complication rate may have an additional cost saving aspect by reducing intensive care unit and hospital stay time.

The cost of blood products is a significant part of hospital expenses and is increasing, with annual rises of 10% or more. Prices driven by increasing numbers of surgical procedures are likely to increase further when demand cannot be matched by the steadily declining donor pool in our aging population. Moreover, directly related costs such as storing, testing and administering blood products are constantly underestimated in hospital budgets, yet these costs can be a significant part of the total cost to the hospital.

Improved patient outcome

Substantial blood savings of up to 50% can be realized through individualized bleeding management and with comprehensive diagnostic results. In particular, thromboelastometry with ROTEM® has been proven to decrease transfusion volumes and shorten durations of hospital stay in elective procedures, such as liver transplantation and cardiac surgery. Similar cost-savings are being investigated in other application fields such as trauma care (polytrauma, brain injury, etc.).